424 related articles for article (PubMed ID: 15220916)
1. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses.
Watanabe T; Kitani A; Murray PJ; Strober W
Nat Immunol; 2004 Aug; 5(8):800-8. PubMed ID: 15220916
[TBL] [Abstract][Full Text] [Related]
2. NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease.
Netea MG; Kullberg BJ; de Jong DJ; Franke B; Sprong T; Naber TH; Drenth JP; Van der Meer JW
Eur J Immunol; 2004 Jul; 34(7):2052-9. PubMed ID: 15214053
[TBL] [Abstract][Full Text] [Related]
3. Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture.
Uehara A; Yang S; Fujimoto Y; Fukase K; Kusumoto S; Shibata K; Sugawara S; Takada H
Cell Microbiol; 2005 Jan; 7(1):53-61. PubMed ID: 15617523
[TBL] [Abstract][Full Text] [Related]
4. How NOD-ing off leads to Crohn disease.
O'Neill LA
Nat Immunol; 2004 Aug; 5(8):776-8. PubMed ID: 15282558
[No Abstract] [Full Text] [Related]
5. Towards an understanding of the role of NOD2/CARD15 in the pathogenesis of Crohn's disease.
Philpott DJ; Viala J
Best Pract Res Clin Gastroenterol; 2004 Jun; 18(3):555-68. PubMed ID: 15157827
[TBL] [Abstract][Full Text] [Related]
6. Genetic susceptibility and regulation of inflammation in Crohn's disease. Relationship with the innate immune system.
Peña AS; Peñate M
Rev Esp Enferm Dig; 2002 Jun; 94(6):351-60. PubMed ID: 12432592
[No Abstract] [Full Text] [Related]
7. Nucleotide-binding-oligomerization domain proteins and toll-like receptors: sensors of the inflammatory bowel diseases' microbial environment.
Mueller T; Podolsky DK
Curr Opin Gastroenterol; 2005 Jul; 21(4):419-25. PubMed ID: 15930981
[TBL] [Abstract][Full Text] [Related]
8. NOD2 regulation of Toll-like receptor responses and the pathogenesis of Crohn's disease.
Watanabe T; Kitani A; Strober W
Gut; 2005 Nov; 54(11):1515-8. PubMed ID: 16227353
[No Abstract] [Full Text] [Related]
9. [From gene to disease; 'frame shift'-mutation in the CARD15-gene and Crohn's disease].
van der Linde K; Kuipers EJ; de Rooij FW; Wilson JH
Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2539-42. PubMed ID: 12532667
[TBL] [Abstract][Full Text] [Related]
10. Heat shock up-regulates expression of Toll-like receptor-2 and Toll-like receptor-4 in human monocytes via p38 kinase signal pathway.
Zhou J; An H; Xu H; Liu S; Cao X
Immunology; 2005 Apr; 114(4):522-30. PubMed ID: 15804289
[TBL] [Abstract][Full Text] [Related]
11. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB.
Gringhuis SI; den Dunnen J; Litjens M; van Het Hof B; van Kooyk Y; Geijtenbeek TB
Immunity; 2007 May; 26(5):605-16. PubMed ID: 17462920
[TBL] [Abstract][Full Text] [Related]
12. Influence of polymorphisms in the NOD1/CARD4 and NOD2/CARD15 genes on the clinical outcome of Helicobacter pylori infection.
Rosenstiel P; Hellmig S; Hampe J; Ott S; Till A; Fischbach W; Sahly H; Lucius R; Fölsch UR; Philpott D; Schreiber S
Cell Microbiol; 2006 Jul; 8(7):1188-98. PubMed ID: 16819970
[TBL] [Abstract][Full Text] [Related]
13. Tetradecanoyl phorbol acetate induces expression of Toll-like receptor 2 in U937 cells: involvement of PKC, ERK, and NF-kappaB.
Jang BC; Jung TY; Paik JH; Kwon YK; Shin SW; Kim SP; Ha JS; Suh MH; Suh SI
Biochem Biophys Res Commun; 2005 Mar; 328(1):70-7. PubMed ID: 15670752
[TBL] [Abstract][Full Text] [Related]
14. Cloning, sequencing and expression analysis of the mouse NOD2/CARD15 gene.
Iwanaga Y; Davey MP; Martin TM; Planck SR; DePriest ML; Baugh MM; Suing CM; Rosenbaum JT
Inflamm Res; 2003 Jun; 52(6):272-6. PubMed ID: 12835899
[TBL] [Abstract][Full Text] [Related]
15. The 3020insC mutation of the NOD2/CARD15 gene in patients with periodontal disease.
Folwaczny M; Glas J; Török HP; Mauermann D; Folwaczny C
Eur J Oral Sci; 2004 Aug; 112(4):316-9. PubMed ID: 15279649
[TBL] [Abstract][Full Text] [Related]
16. Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis.
Watanabe T; Asano N; Murray PJ; Ozato K; Tailor P; Fuss IJ; Kitani A; Strober W
J Clin Invest; 2008 Feb; 118(2):545-59. PubMed ID: 18188453
[TBL] [Abstract][Full Text] [Related]
17. Genes, microbes, and T cells--new therapeutic targets in Crohn's disease.
Elson CO
N Engl J Med; 2002 Feb; 346(8):614-6. PubMed ID: 11856802
[No Abstract] [Full Text] [Related]
18. Impaired innate immunity in Crohn's disease.
Comalada M; Peppelenbosch MP
Trends Mol Med; 2006 Sep; 12(9):397-9. PubMed ID: 16890491
[TBL] [Abstract][Full Text] [Related]
19. Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis.
Watanabe T; Kitani A; Murray PJ; Wakatsuki Y; Fuss IJ; Strober W
Immunity; 2006 Sep; 25(3):473-85. PubMed ID: 16949315
[TBL] [Abstract][Full Text] [Related]
20. Crohn's disease is caused by mutations in the bacterial response protein NOD2.
Press RD
Mol Diagn; 2001 Dec; 6(4):347-8. PubMed ID: 11837220
[No Abstract] [Full Text] [Related]
[Next] [New Search]
